Skip to content

The efficacy of incision/fenestration and steroid ointment application therapy for patients with oral ranula at floor of mouth.

The efficacy of incision/fenestration and steroid ointment application therapy for patients with oral ranula at floor of mouth.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs041250077
Enrollment
35
Registered
2025-08-12
Start date
2025-09-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

There are no particular restrictions.

Interventions

On the day of surgery, the principal investigator/subinvestigator will incise or fenestrate the ranula, and then apply an appropriate amount of dexamethasone ointment to the wound. From the day of sur

Sponsors

Miyamoto Hironori
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who have been diagnosed with oral ranula at the study facility and are scheduled for marsupialization. 2. No age or gender restrictions. 3. Not matter whether the patient is an inpatient or an outpatient. 4. Patients who have given consent to participate in this clinical study from themselves or their family members. If the patient is a minor, consent has been obtained from a legal representative (parent, guardian, or equivalent). However, if the patient is 16 years of age or older, consent has been obtained from the patient themselves in addition to written consent from a legal representative.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of hypersensitivity to steroid ointments (dexamethasone ointment). 2. Patients with pituitary/adrenal disease. 3. Patients with oral infections. 4. Patients who are scheduled to receive steroid treatment such as oral administration, infusion, or inhalation during the clinical study. 5. Pregnant patients. Patients who are breastfeeding and find it difficult to discontinue breastfeeding during this treatment. 6. Patients who have difficulty applying steroid ointment (dexamethasone ointment) by themselves or their families. 7. Patients who are deemed unsuitable as clinical study subjects by the principal investigator/subinvestigator.

Design outcomes

Primary

MeasureTime frame
Whether or not mucous retention cysts of the floor of the mouth recur.

Secondary

MeasureTime frame
1. Recurrence-free rate 2. Surgery time 3. Postoperative complications within 1 month of starting treatment

Contacts

Public ContactHironori Miyamoto

Nagoya City University Hospital

miya0331@me.com+81-52-858-7302

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026